title: Pulmonary heart disease: The heart-lung interaction and its impact on patient phenotypes.
abstract: Pulmonary heart disease (PHD) refers to altered structure or function of the right ventricle occurring in association with abnormal respiratory function. Although nearly always associated with some degree of PH, the degree, nature, severity, and causality of PH in relation to the PHD is not necessarily linear and direct. Abnormal gas exchange is a fundamental underpinning of PHD, affecting pulmonary vascular, cardiac, renal, and neurohormonal systems. Direct and indirect effects of chronic respiratory disease can disrupt the right ventricular-pulmonary arterial (RV-PA) interaction and, likewise, factors such as sympathetic nervous system activation, altered blood viscosity, and salt and water retention can function in a feedback loop to further influence RV-PA function. Left heart function may also be affected, especially in those with pre-existing left heart disease. Thus, the physiologic interactions between abnormal respiratory and cardiovascular function are complex, with PHD representing a heterogeneous end organ effect of an integrated multisystem process. In this review, we propose to separate PHD into two distinct entities, "Type I" and "Type II" PHD. Type I PHD is most common, and refers to subjects with chronic respiratory disease (CRD) where the perturbations in respiratory function dominate over more mild cardiac and circulatory disruptions. In contrast, Type II PHD refers to the smaller subset of patients with more severe pulmonary vascular and right heart dysfunction, whom often present in a fashion similar to patients with PAH. Phenotypic differences are not made by PA pressure alone, but instead by differences in the overall physiology and clinical syndrome. Thus, key differences can be seen in symptomatology, physical signs, cardiac imaging, hemodynamics, and the cardiovascular and gas exchange responses to exercise. Such key baseline differences in the overall physiologic phenotype are likely critical to predicting response to PH specific therapy. Recognizing PHD as distinct phenotypes assists in the necessary distinction of these patients, and may also provide a key clinical and pathophysiologic framework for improved patient selection for future studies investigating the role of pulmonary hypertension-specific therapies in PHD.
authors: Heart Failure and Transplant Cardiology, Pulmonary Hypertension Program, Hospital of University of Pennsylvania, Philadelphia, Pennsylvania, USA.
authors: Paul R
authors: PR
authors: Forfia
authors: Anjali
authors: A
authors: Vaidya
authors: Susan E
authors: SE
authors: Wiegers
keywords: chronic respiratory disease; cor pulmonale; exercise physiology; group 3 pulmonary hypertension; pulmonary heart disease; pulmonary hypertension; pulmonary vascular disease; right ventricular function; ventilatory inefficiency
references: J Clin Invest. 1952 Aug;31(8):770-81
references: 14955529
references: Lancet. 1960 May 28;1(7135):1184-6
references: 13807246
references: Am Rev Respir Dis. 1976 Oct;114(4):775-94
references: 788575
references: J Appl Physiol (1985). 2000 Mar;88(3):926-32
references: 10710387
references: Respirology. 2011 Apr;16(3):451-8
references: 21122030
references: Lung. 2003;181(3):157-66
references: 14565689
references: Respir Physiol. 1968 Jan;4(1):58-72
references: 5639524
references: Chest. 2005 May;127(5):1531-6
references: 15888824
references: Proc Am Thorac Soc. 2008 Feb 15;5(2):200-6
references: 18250213
references: Am J Respir Crit Care Med. 2000 Jan;161(1):216-23
references: 10619823
references: Am J Respir Crit Care Med. 2009 Apr 1;179(7):615-21
references: 19164700
references: Respir Med. 2009 Feb;103(2):317-24
references: 18804360
references: Ann Intern Med. 1980 Sep;93(3):391-8
references: 6776858
references: Thorax. 1995 Aug;50(8):838-45
references: 7570434
references: J Heart Lung Transplant. 2009 Sep;28(9):964-7
references: 19716051
references: Am J Respir Crit Care Med. 2011 Jan 15;183(2):268-76
references: 20709819
references: Clin Chest Med. 2007 Mar;28(1):219-32, x
references: 17338937
references: Chest. 1996 Feb;109(2):380-6
references: 8620709
references: J Appl Physiol (1985). 1986 Apr;60(4):1230-6
references: 3084446
references: Chest. 1990 Apr;97(4):840-4
references: 2138976
references: Eur Respir J Suppl. 2003 Nov;46:33s-40s
references: 14621105
references: Chest. 1988 Oct;94(4):772-8
references: 3139371
references: Arthritis Rheum. 2006 Jan;54(1):184-91
references: 16385514
references: Adv Exp Med Biol. 2009;648:351-60
references: 19536499
references: Eur Respir J. 2008 Nov;32(5):1371-85
references: 18978137
references: Respir Med. 2010 Jan;104(1):121-6
references: 19577458
references: Chest. 2007 Sep;132(3):998-1006
references: 17873194
references: Lancet. 2002 Sep 21;360(9337):895-900
references: 12354470
references: Eur Heart J. 2007 Apr;28(7):785-7
references: 17384088
references: Circulation. 1992 Jul;86(1):12-21
references: 1617764
references: Lancet. 1981 Mar 28;1(8222):681-6
references: 6110912
references: Chron Respir Dis. 2009;6(3):177-85
references: 19643833
references: Thorax. 1997 May;52(5):401-2
references: 9176526
references: Chest. 1990 Feb;97(2):453-60
references: 2298071
references: Circulation. 1980 Dec;62(6):1297-307
references: 7438365
references: J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-S54
references: 19555858
references: Eur Respir J. 2008 Sep;32(3):619-28
references: 18448495
references: Circulation. 2004 Oct 5;110(14):2010-6
references: 15451801
references: Chest. 2009 Jun;135(6):1455-1461
references: 19118270
references: Circulation. 2007 Nov 6;116(19):2191-202
references: 17984389
references: Pneumologie. 2000 Mar;54(3):133-42
references: 10783653
references: Physiol Rev. 1994 Jul;74(3):543-94
references: 8036247
references: Circulation. 2001 Jul 24;104(4):429-35
references: 11468205
references: Circulation. 1982 Oct;66(4):887-94
references: 7116605
references: Am J Respir Crit Care Med. 2005 Jul 15;172(2):189-94
references: 15831842
references: J Clin Anesth. 1996 May;8(3):205-9
references: 8703455
references: Chest. 1998 Jan;113(1):65-70
references: 9440570
references: Cardiovasc Res. 1968 Jan;2(1):84-92
references: 5645469
references: Heart Lung. 2012 Sep-Oct;41(5):512-7
references: 22054725
references: J Appl Physiol. 1966 Mar;21(2):358-64
references: 5934435
references: Am J Respir Crit Care Med. 2003 Mar 1;167(5):735-40
references: 12480614
references: Respiration. 2010;79(5):377-82
references: 19786728
references: Am J Respir Crit Care Med. 2007 Apr 15;175(8):846-50
references: 17272784
references: Sleep Breath. 2009 Mar;13(1):25-34
references: 18615260
references: Eur Respir J. 2005 May;25(5):783-8
references: 15863633
references: Echocardiography. 2006 Oct;23(9):750-5
references: 16999693
references: Respiration. 1995;62(4):185-9
references: 8578013
references: Am J Respir Crit Care Med. 2006 Nov 1;174(9):1034-41
references: 16888289
references: Wien Klin Wochenschr. 2008;120(23-24):749-55
references: 19122986